Many immune-related therapeutic indicators, including PD-1, PD-L1, HER2, IGF2R, CTLA-4, and GD2, are highly expressed in tumor samples [12,13,14,15,16,17,18,37]. This evidence concerns the gene CTLA4 and neoplasm.